Factors influencing ribavirin-induced hemolysis
- 30 June 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 34 (6) , 911-916
- https://doi.org/10.1016/s0168-8278(01)00029-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Fast determination of haptoglobin phenotype and calculation of hemoglobin binding capacity using high pressure gel permeation chromatographyClinica Chimica Acta; International Journal of Clinical Chemistry, 1999
- Hemolytic Anemia and the Treatment of Chronic Hepatitis CJournal of Clinical Gastroenterology, 1999
- Severe anemia following combined α-interferon/ribavirin therapy of chronic hepatitis CJournal of Hepatology, 1998
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine‐sensitive (es)‐nucleoside transportersBritish Journal of Pharmacology, 1998
- Therapy of hepatitis C: Alpha interferon and ribavirinHepatology, 1997
- Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infectionsBone Marrow Transplantation, 1997
- A Pilot Study of Ribavirin Therapy for Chronic Hepatitis CHepatology, 1992
- Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adultsBiochemical Journal, 1955